These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17696949)

  • 21. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness.
    Jin JS; Yu CP; Sun GH; Lin YF; Chiang H; Chao TK; Tsai WC; Sheu LF
    Histol Histopathol; 2006 Dec; 21(12):1287-93. PubMed ID: 16977579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
    Li WT; Jeng YM; Yang CY
    Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
    Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
    Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
    Dong W; Xiang J; Li C; Cao Z; Huang Z
    J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
    Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
    Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
    Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
    Gunal A; Onguru O; Safali M; Beyzadeoglu M
    Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of fascin associated with malignant transformation of sinonasal inverted papilloma.
    Wang AL; Liu HG; Zhang Y
    Chin Med J (Engl); 2007 Mar; 120(5):375-9. PubMed ID: 17376306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma.
    Puppa G; Maisonneuve P; Sonzogni A; Masullo M; Chiappa A; Valerio M; Zampino MG; Franceschetti I; Capelli P; Chilosi M; Menestrina F; Viale G; Pelosi G
    Br J Cancer; 2007 Apr; 96(7):1118-26. PubMed ID: 17375048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
    J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer.
    Pelosi G; Pastorino U; Pasini F; Maissoneuve P; Fraggetta F; Iannucci A; Sonzogni A; De Manzoni G; Terzi A; Durante E; Bresaola E; Pezzella F; Viale G
    Br J Cancer; 2003 Feb; 88(4):537-47. PubMed ID: 12592367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts.
    Ali MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):258-63. PubMed ID: 18554952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
    Won KY; Kim GY; Lim SJ; Park YK; Kim YW
    Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH; Yee H; Goswami S; Shukla PS
    Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics.
    El-Rehim DM; El-Maqsoud NM; El-Hamid AM; El-Bab TK; Galal EM
    Mol Clin Oncol; 2013 Mar; 1(2):297-304. PubMed ID: 24649164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
    Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
    Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?
    Hashimoto Y; Skacel M; Adams JC
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1787-804. PubMed ID: 16002322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.